Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Retention of Bisphosphonate (Zometa) in Patients With Multiple Myeloma or Breast Cancer With Metastases to Bone

NCT00760370 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT00760370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00760370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Retention of Bisphosphonate (Zometa) in Patients With Multiple Myeloma or Breast Cancer With Metastases to Bone
Lead sponsor
Vejle Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
December 31, 2011
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, multiple myeloma